Showing all 2 results
Ambrisentan Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Potency Tablet, packed in high-barrier Alu-Alu blister strips to ensure API stability.
Active Ingredient Strength Primary Clinical Function Ambrisentan USP/Ph.Eur. 5 mg The Initiation Unit: The standard starting dose for adults to establish tolerance and initial pulmonary dilation. Ambrisentan USP/Ph.Eur. 10 mg The Maximum Maintenance Payload: For patients requiring additional symptomatic improvement after the 5 mg dose. Excipients Proprietary Matrix Bio-Optimized System: Engineered to ensure a consistent $T_{max}$ (peak concentration) of approx. 2 hours for reliable daily protection. Aminosalicylic Acid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Delayed-Release (DR) Tablet, packed in moisture-resistant Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function 4-Aminosalicylic Acid USP/BP 500 mg The Standard Titration Unit: Allows for gradual dose escalation to manage gastrointestinal side effects. 4-Aminosalicylic Acid USP/BP 1000 mg The Maintenance Payload: High-dose format for adult MDR-TB regimens requiring up to 8–12g daily. Excipients Acid-Resistant Polymer Enteric Shield System: Engineered to bypass the stomach and release the API in the upper intestine for maximum absorption.
